Literature DB >> 15585321

The role of sphingosine and ceramide kinases in inflammatory responses.

Thomas Baumruker1, Frédéric Bornancin, Andreas Billich.   

Abstract

The 1-phosphates of sphingosine and ceramide (S1P and C1P) have emerged as key representatives of a new group of lipid signalling molecules. S1P is known to act both as an extracellular mediator and as an intracellular 'second messenger,' while C1P currently is only known for its intracellular actions. Therefore, sphingosine and ceramide kinases, the enzymes involved in the generation of these lipid mediators, are now in the spotlight. This review summarizes current information on structure, localization, substrate specificity, activation, and binding partners of these kinases, and then focuses on discoveries in relation to immune cell regulation and inflammation, addressing in particular mast cell activation and degranulation, IL-12 signalling, prostaglandin biosynthesis, monocyte activation, and neutrophil priming.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15585321     DOI: 10.1016/j.imlet.2004.09.001

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  16 in total

Review 1.  Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors.

Authors:  K Alexa Orr Gandy; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2012-07-16

2.  Regulation of the amount of ceramide-1-phosphate synthesized in differentiated human podocytes.

Authors:  Shamroop Kumar Mallela; Alla Mitrofanova; Sandra Merscher; Alessia Fornoni
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-09-02       Impact factor: 4.698

3.  Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.

Authors:  Lynn W Maines; Leo R Fitzpatrick; Cecelia L Green; Yan Zhuang; Charles D Smith
Journal:  Inflammopharmacology       Date:  2010-02-12       Impact factor: 4.473

4.  Cerebrovascular Angiogenic Reprogramming upon LRP1 Repression: Impact on Sphingosine-1-Phosphate-Mediated Signaling in Brain Endothelial Cell Chemotactism.

Authors:  Amélie Vézina; Cyndia Charfi; Alain Zgheib; Borhane Annabi
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

Review 5.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

6.  Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages.

Authors:  Hridayesh Prakash; Anja Lüth; Natalia Grinkina; Daniela Holzer; Raj Wadgaonkar; Alexis Perez Gonzalez; Elsa Anes; Burkhard Kleuser
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

7.  Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3.

Authors:  Angela M Whetzel; David T Bolick; Catherine C Hedrick
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-17       Impact factor: 4.249

Review 8.  The sphingolipid salvage pathway in ceramide metabolism and signaling.

Authors:  Kazuyuki Kitatani; Jolanta Idkowiak-Baldys; Yusuf A Hannun
Journal:  Cell Signal       Date:  2007-12-14       Impact factor: 4.315

9.  Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity.

Authors:  Tamara M Leclercq; Paul A B Moretti; Mathew A Vadas; Stuart M Pitson
Journal:  J Biol Chem       Date:  2008-02-08       Impact factor: 5.157

10.  Regulation of phosphatidic Acid metabolism by sphingolipids in the central nervous system.

Authors:  Susana J Pasquaré; Virginia L Gaveglio; Norma M Giusto
Journal:  J Lipids       Date:  2010-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.